In this prospective trial in oligometastatic renal cell carcinoma (RCC), the first of its kind, stereotactic ablative body radiotherapy was delivered successfully in lieu of systemic therapy. This strategy should be considered in selected patients with oligometastatic RCC.

中文翻译：

---

用 SABR 替代寡转移性肾细胞癌的全身治疗——购买时间还是改变时间？

在这项针对寡转移性肾细胞癌 (RCC) 的前瞻性试验中，首次成功实施了立体定向消融体放射治疗来代替全身治疗。在选定的寡转移性肾细胞癌患者中应考虑这种策略。